Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163
PLOS Biology · 2025-07-11 · 23 (7) · e3003264
DOI: 10.1371/journal.pbio.3003264 ↗At a glance
Journal article in PLOS Biology, published online on 2025-07-11. Written by Ching-Shin Huang and 11 co-authors. Institution: BioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America. Major MEDLINE topics: Haptoglobins, Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, Antigens, CD. Cited 11 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 4.0). Funded by: Pfizer, Inc., Cambridge, MA, USA, Pfizer, Inc.
Abstract (original language)
Intravascular hemolysis releases hemoglobin into the bloodstream, which can damage vascular and renal tissues due to its oxidative nature. Circulating haptoglobin acts as a primary defense by binding to free hemoglobin, forming a haptoglobin–hemoglobin (HpHb) complex that is then recognized and cleared by the CD163 scavenger receptor on macrophages. While the function and structure of HpHb complex are mostly well-defined, the molecular mechanism underlying its interaction with CD163 remains unclear. Here we report the cryo-electron microscopy structures of human CD163 in its unliganded state and in its complex with HpHb. These structures reveal that CD163 functions as a trimer, forming a composite binding site at its center for one protomer of the dimeric HpHb, resulting in a 3:1 binding stoichiometry. In the unliganded state, CD163 can also form a trimer, but in an autoinhibitory configuration that occludes the ligand binding site. Widespread electrostatic interactions mediated by calcium ions are pivotal in both pre-ligand and ligand-bound receptor assemblies. This calcium-dependent mechanism enables CD163/HpHb complexes to assemble and, once internalized, disassemble into individual components upon reaching the endosome, where low calcium and lower pH conditions prevail. Collectively, this study elucidates the molecular mechanism by which CD163-mediated endocytosis efficiently clears different isoforms of HpHb.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- BioMedicine Design, Pfizer, Inc., Cambridge, Massachusetts, United States of America.
- BioMedicine Design, Pfizer, Inc., La Jolla, California, United States of America.
- School of Molecular and Cellular Biology, Faculty of Biological Sciences & Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
- School of Biomedical Sciences, Faculty of Biological Sciences & Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
ORCID profiles: Ching-Shin Huang
Funding
- Pfizer, Inc., Cambridge, MA, USA
- Pfizer, Inc
Cite
APA
Huang, C. S., Wang, H., White, J. B. R., Degtjarik, O., Huynh, C., Brannstrom, K., Horn, M. T., Muench, S. P., Somers, W. S., Chaparro-Riggers, J., Lin, L., & Mosyak, L. (2025). Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163. PLOS Biology, 23(7), e3003264. https://doi.org/10.1371/journal.pbio.3003264
Vancouver
Huang CS, Wang H, White JBR, Degtjarik O, Huynh C, Brannstrom K, et al. Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163. PLOS Biology. 2025;23(7):e3003264. doi:10.1371/journal.pbio.3003264
BibTeX
@article{Huang2025,
author = {Huang, Ching-Shin and Wang, Hui and White, Joshua B R and Degtjarik, Oksana and Huynh, Cindy and Brannstrom, Kristoffer and Horn, Mark T and Muench, Stephen P and Somers, William S and Chaparro-Riggers, Javier and Lin, Laura and Mosyak, Lidia},
title = {Structural elucidation of the haptoglobin–hemoglobin clearance mechanism by macrophage scavenger receptor CD163},
journal = {PLOS Biology},
year = {2025},
volume = {23},
number = {7},
pages = {e3003264},
doi = {10.1371/journal.pbio.3003264}
}
EUVIMED